A New Tuberculosis Drug Under Trial

Publisher:
MSF
Publication Date:
11 June 2011
Tags:
Africa, Health and Medicine, Tuberculosis

While Bedaquiline, a new drug for the treatment of tuberculosis, is still in the clinical evaluation stage, it shows promising results. Doctors Without Borders/Médecins Sans Frontières (MSF) admitted 29,000 people suffering from tuberculosis on first-line treatment in 2012. Long neglected by research efforts, these patients may soon enjoy the benefits of recent innovation.

More on This
South Africa Hailed for 'Revolutionary' Step in Treating TB
South African Men More Likely to Die From TB Than Women - Report
South Africa Pilots Mobile X-Ray Tuberculosis Detection Project
Price of TB Drugs Under the Microscope
What Happened at World's First High-Level UN Meeting On TB

Follow AllAfrica

Most Popular
Africa
across allAfrica.com

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.